Related Experiment Video
Updated: Aug 7, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Tricho-Hepato-Enteric Syndromic Immunodeficiency: Clinical Spectrum, Pathobiology, and Emerging Therapies
Amarilla B Mandola1, Shirly Frizinsky1, Ido Somekh2
1Department of Pediatrics A, Safra Children's Hospital, Jeffrey Modell Foundation Center, Sheba Medical Center, Tel Hashomer, Israel, Pediatric Immunology Services, Safra Children's Hospital, Jeffrey Modell Foundation Center, Sheba Medical Center, Tel Hashomer, Israel, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Tricho-hepato-enteric syndrome (THES) is a rare immune disorder diagnosed through genetic testing. Early recognition of its syndromic features and immune dysregulation is crucial for timely management and improved outcomes.
Area of Science:
- Genetics
- Immunology
- Pediatrics
Background:
- Syndromic inborn errors of immunity (IEIs) present with immune dysfunction, congenital anomalies, and multisystem involvement.
- Tricho-hepato-enteric syndrome (THES) is an ultra-rare autosomal recessive IEI caused by variants in TTC37 or SKIV2L, often diagnosed late due to its diverse clinical spectrum.
Purpose of the Study:
- To detail the clinical, immunological, genetic, and histopathological features of two pediatric THES cases.
- To propose a structured diagnostic pathway for syndromic immunodeficiencies.
Main Methods:
- Retrospective review of clinical data, laboratory results, immune phenotyping, and histopathology in two THES patients.
- Whole-exome sequencing for molecular confirmation of THES diagnosis.
Main Results:
- Both patients exhibited intractable diarrhea, failure to thrive, dysmorphic features, and brittle hair, indicative of THES.
- Immunological findings included inverted CD4/CD8 ratios, humoral immune abnormalities, and poor vaccine responses.
- Histopathology showed chronic active colitis resembling very-early-onset inflammatory bowel disease; genetic analysis revealed pathogenic variants in SKIV2L and TTC37.
Conclusions:
- Prompt diagnosis of THES is facilitated by recognizing syndromic features, comprehensive immune assessment, and early genomic testing.
- Multidisciplinary management, genetic counseling, and exploration of novel therapies are essential for THES patients.
Related Concept Videos
Trichomoniasis
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease III: Crohn's Disease
